Expression of CD138 (syndecan-1) in renal cell carcinoma is reduced with increasing nuclear grade

Applied Immunohistochemistry and Molecular Morphology

Volumn 14, Issue 2, 2006, Pages 173-177

  Gökden, Neriman ^a   Greene, Graham F ^a,b   Bayer Garner, Ilene B ^c   Spencer, Horace J ^a   Sanderson, Ralph D ^a,b   Gökden, Murat ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c MARSHFIELD CLINIC   (United States)

Author keywords

CD138 syndecan 1; Nuclear grade; Renal cell carcinoma

Indexed keywords

HEPARAN SULFATE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B B4; SYNDECAN 1; UNCLASSIFIED DRUG;

ARTICLE; CHROMOPHOBE ADENOMA; CLEAR CELL CARCINOMA; CONTROLLED STUDY; EPITHELIUM CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; METASTASIS; ONCOCYTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE FIXATION; TISSUE SECTION;

ADENOMA, OXYPHILIC; CARCINOMA, RENAL CELL; DOWN-REGULATION; HUMANS; KIDNEY NEOPLASMS; SYNDECAN-1; TUMOR MARKERS, BIOLOGICAL;

EID: 33745374452     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000168592.58721.7d     Document Type: Article

References (19)

1. Carey DJ. Syndecans. Multifunctional cell-surface co-receptors. Biochem J. 1997;327:1-16.
2. Carey DJ. N-Syndecan. Structure and function of a transmembrane heparan sulfate proteoglycan. Perspect Dev Neurobiol. 1996;3:331-346.
3. Liebersbach BF, Sanderson RD. Expression of syndecan-1 inhibits cell invasion into type I collagen. J Biol Chem. 1994;269:20013-20019.
4. Day RM, Hao X, Ilyas M, et al. Changes in the expression of syndecan-1 in the colorectal adenoma-carcinoma sequence. Virchows Arch. 1999;434:121-125.
5. Bayer-Garner IB, Dilday B, Sanderson RD, et al. Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma. Am J Dermatopathol. 2000;22:119-122.
6. Bayer-Garner IB, Sanderson RD, Smoller BR. Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma. J Cutan Pathol. 1999;26:386-390.
7. Anttonen A, Kajanti M, Heikkilä P, et al. Syndecan-1 expression has prognostic significance in head and neck carcinoma. Br J Cancer. 1999;79:558-564.
8. Pulkkinen JO, Penttinen M, Jalkanen M, et al. Syndecan-1: a new prognostic marker in laryngeal cancer. Acta Otolaryngol. 1997;117:312-315.
9. Stanley MJ, Stanley MW, Sanderson RD, et al. Syndecan-1 expression is induced in the stroma of infiltrating breast carcinoma. Am J Clin Pathol. 1999;112:377-383.
10. Rintala M, Inki P, Klemi P, et al. Association of syndecan-1 with tumor grade and histology in primary invasive cervical carcinoma. Gynecol Oncol. 1999;75:372-378.
11. Inki P, Stenbäck F, Grenman S, et al. Immunohistochemical localization of syndecan-1 in normal and pathological human uterine cervix. J Pathol. 1994;172:349-355.
12. Matsumoto A, Ono M, Fujimoto Y, et al. Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer. 1997;74:482-491.
13. Nackaerts K, Verbeken E, Deneffe G, et al. Heparan sulfate proteoglycan expression in human lung-cancer cells. Int J Cancer. 1997;74:335-345.
14. Kumar-Singh S, Jacobs W, Dhaene K, et al. Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol. 1998;186:300-305.
15. Day R, Ilyas M, Daszak P, et al. Expression of syndecan-1 in inflammatory bowel disease and a possible mechanism of heparin therapy. Dig Dis Sci. 1999;44:2508-2515.
16. Chilosi M, Adami F, Lestani M, et al. CD138/Syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies. Mod Pathol. 1999;12:1101-1106.
17. Stanley MJ, Liebersbach BF, Liu W, et al. Heparan sulfate-mediated cell aggregation: syndecans-1 and -4 mediate intercellular adhesion following their transfection into human B lymphoid cells. J Biol Chem. 1995;270:5077-5083.
18. Inki P, Larjava H, Haapasalmi K, et al. Expression of syndecan-1 is induced by differentiation and suppressed by malignant transformation of human keratinocytes. Eur J Cell Biol. 1994;63:43-51.
19. Subramanian SV, Fitzgerald ML, Bernfield M. Regulated shedding of syndecan-1 and -4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem. 1997;272:14713-14720.